| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print November 30, 2007
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Pathology and Biology of Diseases* and Urology, Graduate School of Medicine, Kyoto University, Kyoto; Medical Proteomics, and Inflammation and Immunology, Graduate School of Medicine, Kyoto Prefectural University of Medicine, Kyoto; the Biochemistry Division,¶ National Cancer Center Research Institute, Tokyo; and the Science and Engineering Research Institute,|| Doshisha University, Kyoto, Japan
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
or receptor tyrosine phosphatase β) highly expressed in the RCCs. Analyses revealed genomic amplification up to eightfold. Despite scarcity in the control kidney, the amounts of PTPRZ1 were increased in the kidney after 3 weeks of oxidative stress, and mRNA levels were increased 16
552-fold in the RCCs. Network analysis of the expression revealed the involvement of the β-catenin pathway in the RCCs. In the RCCs, dephosphorylated β-catenin was translocated to nuclei, resulting in the expression of its target genes cyclin D1, c-myc, c-jun, fra-1, and CD44. Furthermore, knockdown of ptprz1 with small interfering RNA (siRNA), in FRCC-001 and FRCC-562 cell lines established from the induced RCCs, decreased the amounts of nuclear β-catenin and suppressed cellular proliferation concomitant with a decrease in the expression of target genes. These results demonstrate that chronic oxidative stress can induce genomic amplification of ptprz1, activating β-catenin pathways without the involvement of Wnt signaling for carcinogenesis. Thus, iron-mediated persistent oxidative stress confers an environment for gene amplification.
-irradiation, and overload of transition metals and certain chemical compounds.1
Many epidemiological studies demonstrated a close association between chronically oxidative conditions and carcinogenesis. Chronic tuberculous pleuritis causes a high incidence of malignant lymphoma2
; chronic Helicobacter pylori infection is associated with a high incidence of gastric cancer3
; inflammatory bowel diseases are risk factors for colorectal cancer4
; a high risk for heptocellular carcinoma is found in patients with genetic hemochromatosis5,6
; exposure to asbestos fibers rich in iron is frequently associated with mesothelioma and lung cancer7
; severe burn by UV radiation is a risk factor for skin cancer8
; and -irradiation causes a high incidence of leukemia.9
As an initiation process under these circumstances and also as a coordinated strategy in proliferating tumor cells,10
oxidative stress appears to play a role in human carcinogenesis. Thus, an analysis that determines genomic and expressional alterations in an established oxidative stress-induced carcinogenesis is of great importance.
An iron chelate, ferric nitrilotriacetate (Fe-NTA) causes oxidative renal proximal tubular damage via a Fenton reaction that ultimately leads to a high incidence of renal cell carcinoma (RCC) in mice11
and rats12
after repeated intraperitoneal administration. This model is intriguing in that 1) more than half of the induced tumors metastasize to the lung and/or invade the peritoneal cavity, resulting in animal mortality13
; 2) evidence exists for the involvement of free radical reactions in carcinogenesis, including not only covalently modified macromolecules (oxidatively modified DNA bases14,15
and lipid peroxidation products16,17
) but also preventive action of 
-tocopherol against carcinogenesis18
; and 3) genetic changes in p16INK4a tumor suppressor gene, especially large deletions,19,20
and expressional alteration of several key genes, including annexin 2 overexpression21
and also loss of thioredixn-binding protein-2 based on methylation of the promoter region,22
have been observed.
Here, we performed array-based comprehensive genomic hybridization and gene expression microarray analyses using Fe-NTA-induced rat RCCs and their cell lines to find amplified oncogenes in this model. A common chromosomal amplification at 4q22 in cancers resulted in the discovery of β-catenin pathway activation via gene amplification and overexpression of ptprz1 protein tyrosine phosphatase.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
The carcinogenesis study was performed as previously described13 using specific pathogen-free male Wistar rats (Shizuoka Laboratory Animal Center, Shizuoka, Japan) or male F1 rats hybrid between Fischer344 and Brown-Norway strains (Charles River, Yokohama, Japan). The animals were kept under close observation and were sacrificed when they showed persistent weight loss and distress. Histological grade of tumor was determined according to the modified World Health Organization classification as we previously described.13 The animal experiment committee of Graduate School of Medicine, Kyoto University approved this experiment. All of the chemicals used were of analytical quality.
Array-Based Comparative Genomic Hybridization
We performed array-based comparative genomic hybridization (CGH) with an Agilent 185K rat genome CGH microarray chip (Agilent Technologies, Santa Clara, CA), as described in the Agilent Oligonucleotide Array-based CGH for Genomic DNA Analysis Protocol ver. 4.0, and analyzed results with CGH Analytics Software (ver. 3.4). For each array, normal kidney tissue was used as a reference and labeled with Cy-3. Samples of interest were each labeled with Cy-5.
Ptprz1 Genome Copy Analysis
Genomic DNA was extracted with a DNA Extractor WB kit (Wako, Osaka, Japan). A Platinum SYBR Green qPCR SuperMix UDG kit (Invitrogen, Carlsbad, CA) and Real-time PCR system 7300 (Applied Biosystems, Foster City, CA) were used. Primer sequences were as follows, based on NW_047689: forward, 5'-CCTTACAGGTGAAAGTCAGC-3'; and reverse, 5'-GGTATACTTTGGCCCACAGT-3' (130-bp product).
Ptprz1 Genome DNA Fluorescent in Situ Hybridization
Three bacterial artificial chromosome clones (CH230–385 M3, CH 230–160 P8, CH 230–418 P21) were extracted with a big bacterial artificial chromosome DNA isolation kit (Princeton Separations, Adelphia, NJ), labeled with biotin-16-dUTP via nick translation (Roche, Tokyo, Japan) and used as probes (2 µg/ml) for hybridization in ULTRAhyb hybridization buffer (Ambion, Austin, TX) as previously described.20 Either formalin-fixed paraffin-embedded sections or cell lines were used on MAS-GP-coated glass slides (Matunami Glass Ind., Ltd., Kishiwada, Japan) after smear preparation.
Gene Expression Microarray
A total of 10 microarrays (Rat Genome 230 2.0; 31,999 genes; Affymetrix Inc., Santa Clara, CA) were used for screening purpose: two for each group of untreated control, Fe-NTA treatment for 1 week, Fe-NTA treatment for 3 weeks, Fe-NTA-induced RCCs with neither peritoneal invasion nor metastasis, and Fe-NTA-induced RCCs with pulmonary metastasis. Total RNA was isolated with Isogen (Nippon Gene Co. Ltd., Tokyo, Japan), and the degree of gene expression was then evaluated with GeneChip analysis (Focus array; Affymetrix) as previously described.23 Network analysis was performed using Ingenuity Pathways Analysis (Ingenuity Systems, Redwood City, CA).
RT-PCR
Total RNA was extracted with TRIzol (Invitrogen), and cDNA was synthesized using RNA PCR kit ver. 3.0 (Takara, Shiga, Japan) with random primers. We then amplified specific cDNA regions for each ptprz1 isoform with PCR based on a previous report24 and NM_013080. Primer sequences were as follows: primer set 1 for A, B, and S forms: forward, 5'-atgcgaatcctgcagagcttcc-3', and reverse, 5'-ggtcagcagacacctctttgtac-3' (1723-bp product); primer set 2 for A and S forms: forward, 5'-ggcctcgggttgtttatgaca-3', and reverse, 5'-tgtgtccgaagcagcatgaa-3' (1700-bp product); primer set 3 for A form: forward, 5'-tcagagcctgcgctctctgaca-3', and reverse, 5'-gtcaacagtgcagctctgcact-3' (1745-bp product); and primer set 4 for A and B forms: forward, 5'-ttaggtattacagcagacagctcc-3', and reverse, 5'-tcagactaaagactccaggctttc-3' (1737-bp product). For quantitative real-time PCR, a Platinum SYBR Green qPCR SuperMix UDG kit (Invitrogen) and Real-time PCR system 7300 (Applied Biosystems) were used. The glyceraldehyde 3-phosphate dehydrogenase gene was used as an internal control as previously described.23 PCR reactions for each target and control genes were performed in triplicate. Primer sequences used were as follows: ptprz1 based on NM_013080: forward, 5'-cccagctggtggttatgattcc-3', and reverse, 5'-cgtgactttgaagctctctcgcaa-3' (104-bp product); cyclinD1 based on NM_171992: forward, 5'-tgtgccatccatgcggaaa-3', and reverse, 5'-gacaagaaacggtccaggtagt-3' (114-bp product); c-myc based on NM_012603: forward, 5'-tgtctatttggggacagtgttc-3', and reverse, 5'-ctgttagcgaagctcacgtt-3' (149-bp product); c-jun based on NM_021835: forward, 5'-gtgaaatgacagctgagtgtctg-3', and reverse, 5'-gtcaacagtctggacttgtgg-3' (141-bp product); fra-1 based on NM_012953: forward, 5'-ctgctaagtgcagaaaccga-3', and reverse, 5'-caaggcgttccttctgctt-3' (129-bp product); and CD44 based on NM_012924: forward, 5'-tttggtggcacacagcttg-3', and reverse, 5'-atggaatacacctgcgtaacgg-3' (104-bp product).
Ptprz1 mRNA In Situ Hybridization
Phosphate-buffered formaldehyde-fixed, paraffin-embedded specimens were used as previously described25 using a DNA probe containing three repeats of ATT (underlined) at the 3' end for T-T dimer formation with an exposure to 10 kJ/m2 UV irradiation (5'-ctgagtatggcctcaaccagtgtgtcgtgaatgaagattattatt-3'). Minor modifications include pretreatment with 20 µg/ml proteinase K (37°C, 20 minutes), use of TDM-2 monoclonal antibody for T-T dimmer (1:4000 dilution),26 and an application of tyramide signal amplification biotin system (PerkinElmer Japan, Yokohama, Japan) for sensitive detection.
Cell Culture
Cells were cultured in Dulbecco’s modified Eagle’s medium (GIBCO, Rockville, MD) containing 5% (NRK52E; Health Science Research Resources Bank, Osaka, Japan) or 10% (FRCC-001 and FRCC-562 cell lines21 ) fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B at 37°C in a humidified 5% CO2 incubator.
Expression Vectors and Transfection
Coding sequence of rat ptprz1 (GenBank accession number NM_013080) was cloned by RT-PCR using cDNA of normal rat cerebrum as a substrate with the following primers: forward primer, 5'-ggggtaccccccacctggagatgcgaatcctgca-3' (KpnI), and reverse primer, 5'-gggggatatcccccttaccgtcaggtcatgggaagt-3' (EcoRV). PCR products were digested with KpnI and EcoRV (recognition sequences underlined) and subcloned into a mammalian expression vector pcDEF3,27 which was transfected into NRK52E cell line with Lipofectamine 2000 (Invitrogen) and selected with 400 to 800 µg/ml G418.
siRNA Experiments
We designed siRNA oligonucleotides through siDirect software.28 The target ptprz1 sequence was 5'-AACCCTTATGCACCAACTAGAAA-3' (6819–6841), and the siRNA was as follows: sense oligonucleotide, 5'-CCCUUAUGCACCAACUAGAAA-3', and antisense, 5'-UCUAGUUGGUGCAUAAGGGUU-3'. The target β-catenin sequence was gagtcagcgacttgttcaaaact (1125 to 1147), and the siRNA was as follows: sense, 5'-GAGUCAGCGACUUGUUCAAAA-3', and antisense, 5'-UUGAACAAGUCGCUGACUCGG-3'. The negative control (NegC; Naito1) was as follows: sense, 5'-GUACCGCACGUCAUUCGUAUC-3', and antisense, 5'-UACGAAUGACGUGCGGUACGU-3' (RNAi Co., Ltd, Tokyo, Japan). FRCC-001 and FRCC-562 were seeded in the complete medium without antibiotics to 30 to 50% confluence, transfected with siRNA oligonucleotides with Lipofectamine 2000, and incubated for 48 to 72 hours to confirm gene expression with quantitative RT-PCR and Western blot analysis.
Fractionation, Immunoprecipitation, and Western blot
These were done as previously described22,29 except that 0.2 mmol/L Na3VO4, 50 mmol/L NaF, 1 mmol/L dithiothreitol, and 5.7 µg/ml aprotinine were included in the lysis buffer. Antibodies used were as follows: PTPRZ1 (clone 12; 1:100; BD Biosciences, San Jose, CA), β-catenin (clone 14; 1:100), phosphotyrosine (06-427; 1:100; Upstate, Lake Placid, NY), phospho-β-catenin (Ser33/37/Thr41; 1:1000; Cell Signaling Technology, Danvers, MA), and proliferating cell nuclear antigen (clone PC10; 1:3000; BioGenex, San Ramon, CA).
Immunohistochemistry and Immunocytochemistry
This was performed as previously described22 with minor modifications. For the immunohistochemistry of paraffin-embedded specimens, the following antibodies were used: β-catenin (clone 196621; 1:100; R&D Systems, Inc., Minneapolis, MN), c-myc (clone 9E10; 1:50; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and cyclin D1 (SP4; 1:50; NeoMarkers, Inc., Fremont, CA). Antigen retrieval was performed by autoclaving at 121°C for 15 minutes in 10 mmol/L citrate buffer at pH 6.0. For the immunocytochemistry, cells grown on Lab-Tek II Chamber Slide w/Cover (Nalge Nunc International, Naperville, IL) at approximately 70% confluence were fixed with cold methanol for 10 minutes, followed by permeation with 0.5% Triton X-100 for 10 minutes at room temperature. The same antibody against β-catenin was used at a dilution of 1:100. A tyramide signal amplification biotin system (PerkinElmer) was used to increase sensitivity. FITC-avidin and nuclear counterstaining with propidium iodide were used. Images were analyzed with confocal laser microscopy (Fluoview, Olympus, Osaka, Japan).
Cell Proliferation Analysis
Cells were seeded in a six-well plate at first in Dulbecco’s modified Eagle’s medium with serum but without antibiotics. After 24 hours, siRNA oligonucleotides for ptprz1 were transfected, followed by cell counting starting from 24 hours after transfection to the fifth day in triplicate.
Statistical Analysis
Statistical analyses were performed with an unpaired t-test in which P < 0.05 was considered as statistically significant.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
We analyzed 13 Fe-NTA-induced rat RCCs and 2 cell lines established from them with array-based comparative genomic hybridization analyses. Chromosome 4q22 revealed the highest incidence of common genomic amplification among the 20 autosomes and X chromosome (Figure 1A)
. Detailed reports of the whole CGH analyses will be published elsewhere (S. Akatsuka and S. Toyokuni, unpublished data). At the same time, we analyzed four primary RCCs (two nonmetastatic and two metastatic tumors) with gene expression microarray analyses (Tables 1 and 2
; Gene Expression Omnibus accession number GSE7625). With the expression microarray analyses, ptprz1 was the fifth and sixth in the lists of up-regulated genes in nonmetastatic and metastatic RCCs, respectively, and was present on chromosome 4q22. Thus, we decided to focus on ptprz1 based on these two sets of data. Quantitative PCR analyses revealed that 7 of 11 primary RCCs showed genomic amplification of ptprz1 with 5 tumors showing more than fourfold increase (Figure 1B)
. We used fluorescence in situ hybridization analyses to confirm the amplification. In high-copy number tumors, a significantly increased number of signals were observed, whereas control cells showed two or less. Data obtained from cell lines were clearer because of the optimal fixation (Figure 1C)
.
|
|
To differentiate three isoforms of ptprz1 reported,24
we designed specific primers for RT-PCR analyses (Figure 2A)
and found that the B isoform is the major isoform in tumors (Figure 2B)
. Thus, we focused on the B isoform. All of the primary RCCs examined showed 16552-fold increases in ptprz1 expression in comparison with that of a normal untreated kidney (Figure 2C)
. In situ hybridization analyses confirmed the results, revealing abundant staining in the cytoplasm of RCC cells (Figure 2D)
. At the protein level, repeated treatment of Fe-NTA for 3 weeks increased PTPRZ1 with a further increase in tumors (Figure 2E)
. We compared four parameters (pulmonary metastasis, grade, peritoneal invasion and tumor size) of the primary RCCs with mRNA levels and found that morphological grade13
and size of the tumor were proportionally associated (Figure 2F)
.
|
Because network analysis of gene expression microarray data pointed out the involvement of the β-catenin signaling pathway, we studied the status of β-catenin and its downstream genes such as cyclinD1, c-jun, c-myc, fra-1, and CD44 with quantitative PCR and immunohistochemistry. In the Fe-NTA-induced RCCs analyzed, all of the five β-catenin downstream genes were overexpressed, whereas β-catenin expression was not significantly increased (Figure 3A)
. Paraffin-embedded specimens were used for immunohistochemistry. Weak immunostaining of β-catenin was observed in the distal tubules of normal kidney but not in the proximal tubules where Fe-NTA-induced RCCs are believed to be originated, whereas RCCs showed moderate immunopositivity in the cytoplasm and weak to moderate immunopositivity in the nuclei, suggesting that β-catenin abundance and translocation may play an important role in the downstream regulation. RCCs revealed weak to moderate immunopositivity of c-myc, and all of the RCCs showed strong nuclear immunopositivity for cyclin D1 (Figure 3B)
. These results strongly indicated the involvement of β-catenin pathway in the molecular mechanism of Fe-NTA-induced renal carcinogenesis. To demonstrate the causal relationship of ptprz1 and β-catenin-downstream genes, we used cell culture systems thereafter.
|
. Next, we performed ptprz1 transfection to NRK52E cells and found that nuclear dephosphorylated β-catenin was significantly increased and that tyrosine, but not serine/threonine, residues were the target amino acid for dephosphorylation (Figure 4, B and C)
. This was accompanied by the expressional increase in the β-catenin downstream target genes such as cyclinD1, c-jun, c-myc, fra-1, and CD44, which was abolished with the simultaneous transfection of β-catenin siRNA, demonstrating that PTPRZ1 is upstream of β-catenin (Figure 5A)
. Furthermore, we performed an siRNA transfection study of ptprz1 in the two RCC cell lines. With this procedure, nuclear β-catenin was significantly decreased with a relative increase in phosphorylated β-catenin at tyrosine (Figure 4B)
. This was accompanied by a marked expressional decrease in the β-catenin target genes (Figure 5, B and C)
. As seen by the nuclear presence of unphosphorylated β-catenin and the expressional increase in β-catenin downstream target genes, the endpoints were associated with cell proliferation and the levels of proliferating cell nuclear antigen (Figure 5, D–G)
.
|
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Previously, Hunt et al33 reported that chronic exposure of HA1 fibroblasts to increasing concentrations of H2O2 or O2 causes catalase gene amplification with increased amounts of message and protein and also discussed the results in association with the resistance against chemotherapeutic drugs in which pharmacological effects depend on oxidative stress. Our present findings are distinct from theirs in the following contexts: 1) gene amplification occurred in nonimmortalized cells in vivo at multiple different locations, suggesting either the presence of episomal/double minute chromosomes or multiple integration, and 2) the amplified genes were not necessarily associated with resistance to chronic oxidative stress. This is of note, considering the fact that a certain population of human cancers presents gene amplification, including the HER-2/neu proto-oncogene in breast cancers.34,35 The results indicate that persistent oxidative stress is one of the driving forces for gene amplification.
We have integrated the results from CGH analysis and gene expression microarray analysis and focused on ptprz1 (also called protein tyrosine phosphatase or receptor protein tyrosine phosphatase β) in the present study. All of the 13 Fe-NTA-induced RCCs and two cell lines showed overexpression of ptprz1, whereas approximately one-half of them acquired gene amplification. Overexpression of ptprz1 was observed after as early as 3 weeks of persistent oxidative stress. These results suggest that overexpression and the possible associated open chromatin structure are necessary but probably not enough for the gene amplification. Other possible factors involved are neighbor gene effect and chromosome territory. It is now believed that genomic DNA corresponding to certain chromosomes shares a rather fixed stereographical position in nuclei even in interphase.36,37
Thus, a three-dimensional understanding of the neighboring genes would be necessary to understand fully the mechanism of gene amplification. Recently, we found that there are fragile sites (oxidative DNA base modifications) against oxidative stress in the genome using a novel method of DNA immunoprecipitation.15
Genome replication, repair, and recombination should further be considered to elucidate the gene-amplifying mechanism. This carcinogenesis model presents an ideal material for further investigation.
We performed functional analyses on ptprz1 expression using an untransformed rat renal tubular cell line and two cell lines derived from Fe-NTA-induced rat RCCs. Ptprz1 mRNA was abundantly expressed in the cerebrum and cerebellum in rats but was extremely low in the heart, lung, liver, kidney, and stomach (approximately 1/100; data not shown). The major isoform of ptprz1 in this model was the B isoform, one of the major isoforms in adult brain,24 and chronic oxidative stress increased the expression of ptprz1 in the kidney. So far, we have not yet identified the core consensus sequences in the promoter region of ptprz1 that responded to chronic oxidative stress, but hypoxia-inducible factor-2 could be involved in this process because recent study suggested that hypoxia-inducible factor-2 overexpression is important in the development of renal carcinoma in patients with von Hippel Lindau tumor suppressor protein.38,39 The A isoform was present during the prenatal period of rat brain and decreased rapidly after birth. Isoform B is the most deficient in the modification with carbohydrates among the three forms but retains cytoplasmic phosphatase domain.24 With this information, we decided to identify the signal pathways involved downstream of the B isoform.
We focused on the β-catenin pathway because network analysis of the gene expression microarray data on RCCs indicated the involvement of this pathway. The β-catenin transcription coactivator is a key transducer of the Wnt signaling in the canonical pathway. In the absence of Wnt, a multiprotein destruction complex containing glycogen synthetase β, axin, disheveled, casein kinase 1, and adenomatous polyposis coli facilitates β-catenin degradation by the proteasome.40 In our results, we add a novel switching mechanism of this pathway.
In the previous reports, function of ptprz1 in cancer has been controversial. Meng et al reported that pleiotrophin,41
a platelet-derived growth factor-inducible cytokine and a proto-oncogene, interacts with PTPRZ1 in a glioblastoma cell line (U373-MG) to inactivate its catalytic activity, leading to an increase in the tyrosine phosphorylation levels of β-catenin.42
In contrast, it was recently reported that targeting of PTPRZ1 with a monoclonal antibody delays tumor growth in a glioblastoma model.43,44
We found that modulation of tyrosine phosphorylation in β-catenin controlled by ptprz1 is a key process of the β-catenin pathway in this model. Activation of neither pleiotrophin nor Wnt signaling (Wnt2b, Wnt4, or Wnt5a) was observed (GEO accession number GSE7625; data not shown), but β-catenin was translocated to the nucleus, and the downstream target genes of β-catenin were activated in this model. This type of activation appears to be cell specific, considering the fact that normal renal proximal tubular cells show undetectable levels of ptprz1 mRNA. Ptprz1 has recently been identified as important in the recovery from demyelinating lesions,45
is associated with susceptibility to VacA of Helicobacter pylori in murine stomach,46
and was up-regulated after hypoxia-inducible factor-2 transfection in HEK293T (adenovirus-transformed human fetal kidney cells).47
It is possible to interpret from our results that cancer cells use metabolisms similar to fetal tissues in that they proliferate rapidly in a hypoxic environment.48
2-18F-fluoro-2-deoxy-D-glucose, a radioactive derivative of glucose, is widely used for the diagnosis of cancer, based on the increased glucose consumption of cancer cells.49
Our previous observation in this carcinogenesis model that thioredoxin-binding protein-2 is inactivated via methylation of the promoter region, leading to the activation of glycolytic pathway via thioredoxin system,22,50
supports this hypothesis.
In conclusion, we show for the first time, to our knowledge, that chronic oxidative stress causes gene amplification in vivo through a combination of comprehensive array-based CGH and gene expression microarrray analyses in an oxidative stress-induced carcinogenesis model. Furthermore, we found a novel β-catenin signal activation mechanism through overexpression of ptprz1 protein tyrosine phosphatase. Oxidative stress is closely associated not only with carcinogenesis but also with tumor biology.10,31 We believe that oxidative stress, especially of a chronic nature, presents an environment for competitive cell proliferation rather than cooperative cell survival, giving opportunities for selection. We do not know at present whether activation of the β-catenin pathway through ptprz1 amplification is a specific event only in renal tubular cells or oxidative stress-induced carcinogenesis. Because gene amplification in human cancer is often associated with poor prognosis51 and is a mechanism of resistance to therapies,52 this animal model confers an intriguing opportunity not only for the elucidation of carcinogenesis toward cancer prevention but also of therapeutic resistance.
|
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a MEXT grant (Special Coordination Funds for Promoting Science and Technology), a grant of Long-range Research Initiative by Japan Chemical Industry Association, and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan.
Accepted for publication September 6, 2007.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
-Tocopherol induces calnexin in renal tubular cells: another protective mechanism against free radical-induced cellular damage. Arch Biochem Biophys 2006, 453:168-178[CrossRef][Medline] to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 2002, 1:247-255[CrossRef][Medline] and hypoxia-inducible factor-2 in HEK293T cells. Cancer Res 2005, 65:3299-3306
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
